Stockreport

GSK and Vir Biotechnology enter collaboration to find coronavirus solutions

Vir Biotechnology, Inc.  (VIR) 
PDF Companies will combine their unique scientific and technical expertise to combat COVID-19 and potential future coronavirus outbreaksPromising antibody candidates for SAR [Read more]